| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |